These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 8205642)

  • 41. Measles vaccine efficacy in children previously vaccinated at 12 months of age.
    Marks JS; Halpin TJ; Orenstein WA
    Pediatrics; 1978 Dec; 62(6):955-60. PubMed ID: 733423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measles incidence before and after supplementary vaccination activities--Lusaka, Zambia, 1996-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(24):513-6. PubMed ID: 11432675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measles mortality in India: a review of community based studies.
    Singh J; Sharma RS; Verghese T
    J Commun Dis; 1994 Dec; 26(4):203-14. PubMed ID: 7759802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measles vaccine efficacy in India: a review.
    Singh J; Datta KK
    J Commun Dis; 1997 Mar; 29(1):47-56. PubMed ID: 9282529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Measles outbreaks in the Bern canton].
    Maurer AM; Mühlemann K
    Schweiz Med Wochenschr; 1998 Feb; 128(9):317-22. PubMed ID: 9544458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The epidemiology of measles in England and Wales since the 1994 vaccination campaign.
    Gay N; Ramsay M; Cohen B; Hesketh L; Morgan-Capner P; Brown D; Miller E
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R17-21. PubMed ID: 9046124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Description and survey of a measles epidemic in Burkina Faso].
    Schlumberger M; Sawadogo I; Sanou C; Traoré A; Rümke H; Roisin A
    Sante; 1995; 5(1):31-5. PubMed ID: 7894827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The changing age ecology of measles and its implications on measles control.
    Marufu T
    Cent Afr J Med; 1992 Jun; 38(6):208-14. PubMed ID: 1394401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.
    Domínguez A; Torner N; Barrabeig I; Rovira A; Rius C; Cayla J; Plasencia E; Minguell S; Sala MR; Martínez A; Costa J; Mosquera M; Cabezas C;
    Clin Infect Dis; 2008 Nov; 47(9):1143-9. PubMed ID: 18823269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles incidence before and after mass vaccination campaigns in Burkina Faso.
    Kambiré C; Konde MK; Yaméogo A; Tiendrébéogo SR; Ouédraogo RT; Otten MW; Cairns KL; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S80-5. PubMed ID: 12721896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress in accelerated measles control in the People's Republic of China, 1991-2000.
    Lixia W; Guang Z; Lee LA; Zhiwei Y; Jingjin Y; Jun Z; Xiaofeng L; Chang X; Huqun B
    J Infect Dis; 2003 May; 187 Suppl 1():S252-7. PubMed ID: 12721922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002.
    Otten MW; Okwo-Bele JM; Kezaala R; Biellik R; Eggers R; Nshimirimana D
    J Infect Dis; 2003 May; 187 Suppl 1():S36-43. PubMed ID: 12721884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severity of measles: a study at the Queen Sirikit National Institute of Child Health.
    Ariyasriwatana C; Kalayanarooj S
    J Med Assoc Thai; 2004 Jun; 87(6):581-8. PubMed ID: 15279332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China.
    Chuang SK; Lau YL; Lim WL; Chow CB; Tsang T; Tse LY
    Bull World Health Organ; 2002; 80(7):585-91. PubMed ID: 12163924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.